High SARS-CoV-2 Prevalence among Healthcare Workers in Cochabamba, Bolivia

Viruses. 2022 Jan 25;14(2):232. doi: 10.3390/v14020232.

Abstract

Healthcare workers (HCWs) are at increased risk of SARS-CoV-2 infection. The aim of the study was to estimate the SARS-CoV-2 seroprevalence among HCWs in Cochabamba, Bolivia and to determine the potential risk factors. In January 2021, a cross-sectional SARS-CoV-2 seroprevalence study was conducted in 783 volunteer clinical and non-clinical HCWs in tertiary care facilities. It was based on IgG detection using ELISA, chemiluminiscence, and seroneutralisation tests from dried blood spots. Analysis revealed a high seroprevalence (43.4%) of SARS-CoV-2 IgG antibodies. The combination of anosmia and ageusia (OR: 68.11; 95%-CI 24.83-186.80) was predictive of seropositivity. Belonging to the cleaning staff (OR: 1.94; 95%-CI 1.09-3.45), having more than two children in the same house (OR: 1.74; 95%-CI 1.12-2.71), and having been in contact with a close relative with COVID-19 (OR: 3.53; 95%-CI 2.24-5.58) were identified as risk factors for seropositivity in a multivariate analysis. A total of 47.5% of participants had received medication for COVID-19 treatment or prevention, and only ~50% of symptomatic subjects accessed PCR or antigenic testing. This study confirms a massive SARS-CoV-2 attack rate among HCWs in Cochabamba by the end of January 2021. The main risk factors identified are having a low-skilled job, living with children, and having been in contact with an infected relative in the household.

Keywords: Bolivia; SARS-CoV-2; healthcare workers; seroprevalence.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Antibodies, Viral / blood*
  • Antibodies, Viral / immunology
  • Bolivia / epidemiology
  • COVID-19 / epidemiology*
  • COVID-19 / immunology*
  • Cross-Sectional Studies
  • Female
  • Health Personnel / statistics & numerical data*
  • Humans
  • Immunoglobulin G / blood
  • Immunoglobulin G / immunology
  • Male
  • Middle Aged
  • Prevalence
  • Risk Factors
  • SARS-CoV-2 / immunology
  • SARS-CoV-2 / pathogenicity
  • Seroepidemiologic Studies
  • Tertiary Healthcare / statistics & numerical data
  • Young Adult

Substances

  • Antibodies, Viral
  • Immunoglobulin G